IRCT2016031727095N1 IRCT 2016-05-24 Shahid Beheshti University of Medical Sciences and Health Services The effect of topical minoxidil plus betamethasone on androgenetic alopecia Randomized Clinical Trial Comparing 5% Topical Minoxidil and 5% Topical Minoxidil plus Topical Betamethasone for the Treatment of Androgenetic Alopecia in Iranian Men 2016-04-03 anticipated 60 Complete https://irct.ir/trial/22283 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 3 Androgenetic Alopecia. Intervention 1: In the first visit we will take a biopsy specimen from scalp for routine histopathological studies. A 2*2 centimeters area of scalp will be photographed by a trichoscope for the purpose of counting. This group will receive topical 5% minoxidil plus betamethasone (0.1%) (45 milliliters) plus 70-degree alcohol up to 100 milliliters. The subjects will be visited every 4 weeks for 6 months. At each visit, their hairs will be photographed for the purposes of counting and comparing with previous photographs. After six month of initiating treatment subjects will be asked to discontinue therapy for 3 months and pattern and rate of hair loss will be analyzed. Intervention 2: In the first visit we will take a biopsy specimen from scalp for routine histopathological studies. A 2*2 centimeters area of scalp will be photographed by a trichoscope for the purpose of counting. This group will receive topical 5% minoxidil. The subjects will be visited every 4 weeks for 6 months. At each visit, their hairs will be photographed for the purposes of counting and comparing with previous photographs. After six month of initiating treatment subjects will be asked to discontinue therapy for 3 months and pattern and rate of hair loss will be analyzed.